In February and March 2020, two mass swab testing campaigns were conducted in Vo', Italy. In May 2020, we tested 86% of the Vo' population with three immuno-assays detecting antibodies against the spike and nucleocapsid antigens, a neutralisation assay and Polymerase Chain Reaction (PCR). Subjects testing positive to PCR in February/March or a serological assay in May were tested again in November. Here we report on the results of the analysis of the May and November surveys. We estimate a seroprevalence of 3.5% (95% Credible Interval (CrI): 2.8-4.3%) in May. In November, 98.8% (95% Confidence Interval (CI): 93.7-100.0%) of sera which tested positive in May still reacted against at least one antigen; 18.6% (95% CI: 11.0-28.5%) showed an increase of antibody or neutralisation reactivity from May. Analysis of the serostatus of the members of 1,118 households indicates a 26.0% (95% CrI: 17.2-36.9%) Susceptible-Infectious Transmission Probability. Contact tracing had limited impact on epidemic suppression.

SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'

Lavezzo, Enrico;Manuto, Laura;Pacenti, Monia;Boldrin, Caterina;Saluzzo, Francesca;Franchin, Elisa;Del Vecchio, Claudia;Caldart, Federico;Castelli, Gioele;Nicoletti, Michele;Nieddu, Eleonora;Salvadoretti, Elisa;Labella, Beatrice;Fava, Ludovico;Guglielmo, Simone;Fascina, Mariateresa;Grazioli, Marco;Alvisi, Gualtiero;Lisi, Vittoria;Rossi, Lucia;Castagliuolo, Ignazio;Merigliano, Stefano;Plebani, Mario;Padoan, Andrea;Brazzale, Alessandra R;Toppo, Stefano;Crisanti, Andrea
2021

Abstract

In February and March 2020, two mass swab testing campaigns were conducted in Vo', Italy. In May 2020, we tested 86% of the Vo' population with three immuno-assays detecting antibodies against the spike and nucleocapsid antigens, a neutralisation assay and Polymerase Chain Reaction (PCR). Subjects testing positive to PCR in February/March or a serological assay in May were tested again in November. Here we report on the results of the analysis of the May and November surveys. We estimate a seroprevalence of 3.5% (95% Credible Interval (CrI): 2.8-4.3%) in May. In November, 98.8% (95% Confidence Interval (CI): 93.7-100.0%) of sera which tested positive in May still reacted against at least one antigen; 18.6% (95% CI: 11.0-28.5%) showed an increase of antibody or neutralisation reactivity from May. Analysis of the serostatus of the members of 1,118 households indicates a 26.0% (95% CrI: 17.2-36.9%) Susceptible-Infectious Transmission Probability. Contact tracing had limited impact on epidemic suppression.
File in questo prodotto:
File Dimensione Formato  
Lavezzo et al 2021.pdf

accesso aperto

Descrizione: Paper
Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 805.29 kB
Formato Adobe PDF
805.29 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3396249
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 31
social impact